This year’s Nobel Prize in Chemistry has been awarded to the pioneers of MOFs, recognising a class of materials that
Vector Bioscience Cambridge has been selected to join the Future Medicines Accelerator, a programme delivered by LYVA Labs and funded
At Vector Bioscience Cambridge, we work in close collaboration with Prof. David Fairen-Jimenez’s research group at the University of Cambridge.
Vector Bioscience Cambridge has established a new collaboration with researchers from the University of Glasgow to develop and evaluate a
We are pleased to announce that Vector Bioscience Cambridge has joined the Milner Therapeutics Institute as an Affiliated Company. The
We are pleased to announce that Vector Bioscience Cambridge has joined the EU4MOFs COST Action network, a European initiative focused
We are pleased to announce that Vector Bioscience Cambridge is now an official member of the BioIndustry Association (BIA), the
Vector Bioscience Shortlisted for Business Weekly Awards 2024 We are delighted to share that Vector Bioscience Cambridge was shortlisted in
Lluna Gallego joins Panel at Cambridge Judge Business School We are pleased to share that our co-founder, Lluna Gallego, participated
Tech Tales #4 Precision in Drug Delivery – How Our NanoShuttles Work At Vector Bioscience Cambridge, our MOF-based nano-shuttle technology